Cardiovascular Monitoring and Diagnostic Devices Market to Reach USD 9.91 Bn by 2035

According to analysts at Vantage Market Research, the Global Cardiovascular Monitoring and Diagnostics Devices Market size is worth USD 3.31 Billion in 2024 and is projected to reach USD 9.91 Billion by 2035, growing at a CAGR (Compound Annual Growth Rate) of 10.5% from 2024 to 2035. Key trends of market include advancements in AI-powered diagnostics, growing adoption of wearable devices, integration with telemedicine, miniaturization of devices, and rising focus on preventive care. 

Market Overview

Cardiac monitoring devices play a critical role in continuously tracking heart activity to detect chronic conditions like stroke and heart failure drives cardiovascular monitoring and diagnostics devices market trend. By focusing on structural and functional abnormalities of the heart and arteries, these devices help identify and monitor disease progression. The prevalence of heart failure is on the rise. According to the American Heart Association bbg, the number of heart failure patients is projected to increase by 46% by 2030, affecting over 8 million people in the U.S. alone. Globally, congestive heart failure impacts 22 million individuals, with 2 million new cases reported annually. This condition, which claims the lives of 8.5% of the U.S. population each year, remains a leading cause of death.

Subcutaneous cardiac monitor devices (SCRMs) represent an advanced technology designed to monitor known arrhythmias, such as atrial fibrillation (AF), or to detect rare tachyarrhythmias and bradyarrhythmias in patients at risk of sudden cardiac death. The field of cardiac diagnostic and monitoring devices is rapidly evolving, extending beyond traditional electrocardiographic (ECG) and blood pressure monitoring. While ambulatory ECG (AECG) monitoring remains a cornerstone diagnostic tool widely used by physicians, the focus is expanding to include more advanced solutions.

Biotricity announced the upcoming launch of its FDA-approved wireless wearable cardiac monitoring device

• In April 2022, Biotricity announced the upcoming launch of its FDA-approved wireless wearable cardiac monitoring device, Biotres. Pre-orders for the device began in February 2022, targeting physicians, medical practices, hospitals, and individuals

Key Takeaways from the Report

• In 2024, North America dominated the market with 41.5% market share. Market is driven by its well-established healthcare infrastructure and rapid adoption of new technologies
• In 2024, Based on the Product, the ECG Devices category accounted for significant market share of 36.3%. The segment is driven due to its accuracy in assessing the electrical and muscular functions of the heart, and monitoring heart rate and rhythm
• By End User, Hospital dominated the largest market share in 2024. The segment is driven by factors such as the growing number of patients with various heart conditions requiring hospitalization, favorable reimbursement policies

Top Companies

• Philips Healthcare
• GE Healthcare
• Nihon Kohden
• Schiller AG
• Opto Circuits (India) Limited
• Bittium Corporation
• VivaQuant
• Welch Allyn
• Fukuda Denshi Co. Ltd
• Lidco Group plc.
• Biotricity Inc.

Report Coverage

Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all key aspects of the market, including dynamics such as drivers, restraints, opportunities, and challenges, alongside the latest industry trends. Our analysis includes an in-depth technology roadmap, product life cycle evaluation, and PESTLE analysis, ensuring a thorough understanding of the market environment. We also assess GDP growth outlooks, examine regional market landscapes, and evaluate the impact of major events like the COVID-19 pandemic. Additionally, our reports feature a detailed competitive landscape, including company market shares and profiles, providing actionable intelligence to empower your business strategies.

Latest News

GE Healthcare Launches Portrait Mobile: Advanced Wireless Patient Monitoring System to Enhance Outcomes

• In June 2022, GE Healthcare unveiled Portrait Mobile, a wireless patient monitoring solution that enables continuous observation throughout a patient’s hospital stay. By aiding clinicians in identifying early signs of patient deterioration, the system can help reduce ICU admissions and hospital stay durations, improving overall patient outcomes